Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (24)

2023

  1. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  2. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  3. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  4. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

2022

  1. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

  2. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO

    ERJ Open Research, Vol. 8, Núm. 3

  3. Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map

    Journal of Asthma, Vol. 59, Núm. 10, pp. 1997-2007

2021

  1. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 42-50

  2. Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil

    Jornal Brasileiro de Pneumologia, Vol. 47, Núm. 3

2020

  1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

  2. Inhaled dry powder antibiotics in patients with non-cystic fibrosis bronchiectasis: Efficacy and safety in a real-life study

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-11

  3. The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 17, Núm. 4, pp. 346-354

2019

  1. Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia

    International Journal of Tuberculosis and Lung Disease, Vol. 23, Núm. 10, pp. 1100-1106

2018

  1. Alpha-1 antitrypsin deficiency: Outstanding questions and future directions

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

  2. Geographical Distribution of COPD Prevalence in the Americas

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 15, Núm. 4, pp. 317-325

  3. Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the spanish registry (REDAAT)

    International Journal of COPD, Vol. 13, pp. 1001-1007

2017

  1. Alpha-1 antitrypsin Pi*SZ genotype: Estimated prevalence and number of SZ subjects worldwide

    International Journal of COPD, Vol. 12, pp. 1683-1694

  2. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: An update

    International Journal of COPD, Vol. 12, pp. 561-569

  3. Etiología de las bronquiectasias en una cohorte de 2.047 pacientes. Análisis del registro histórico español

    Archivos de Bronconeumologia, Vol. 53, Núm. 7, pp. 366-374

  4. Seasonal variability in clinical care of COPD outpatients: Results from the andalusian COPD audit

    International Journal of COPD, Vol. 12, pp. 785-792